
Sign up to save your podcasts
Or


On this week’s Tech Nation, spurred by the re-opening of expeditions to the summit of Mount Everest, after a one-year closure due to COVID-19, a 1993 interview with Sir Edmund Hillary, who with his climbing partner, Sherpa Tenzing Norgay, was the first to reach the summit. Then Dr. Gene Kinney, the President & CEO of Prothena Biosciences, a new drug in clinical trials for Parkinson’s. How Parkinson’s unfolds in the brain, the idea behind how this drug, and the hope of slowing, if not stopping, disease progress.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, spurred by the re-opening of expeditions to the summit of Mount Everest, after a one-year closure due to COVID-19, a 1993 interview with Sir Edmund Hillary, who with his climbing partner, Sherpa Tenzing Norgay, was the first to reach the summit. Then Dr. Gene Kinney, the President & CEO of Prothena Biosciences, a new drug in clinical trials for Parkinson’s. How Parkinson’s unfolds in the brain, the idea behind how this drug, and the hope of slowing, if not stopping, disease progress.

21,954 Listeners

43,837 Listeners

32,246 Listeners

38,430 Listeners

6,881 Listeners

43,687 Listeners

27,011 Listeners

2,891 Listeners

9,238 Listeners

467 Listeners

736 Listeners

935 Listeners

6,467 Listeners

941 Listeners

33 Listeners